Your browser doesn't support javascript.
loading
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.
Fu, Siqing; Corr, Bradley R; Culm-Merdek, Kerry; Mockbee, Colleen; Youssoufian, Hagop; Stagg, Robert; Naumann, R Wendel; Wenham, Robert M; Rosengarten, Rafael D; Benjamin, Laura; Hamilton, Erika Paige; Moore, Kathleen N.
Afiliação
  • Fu S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Corr BR; University of Colorado Hospital, Aurora, CO.
  • Culm-Merdek K; OncXerna Therapeutics Inc, Waltham, MA.
  • Mockbee C; OncXerna Therapeutics Inc, Waltham, MA.
  • Youssoufian H; OncXerna Therapeutics Inc, Waltham, MA.
  • Stagg R; OncoMed Pharmaceuticals Inc, Redwood City, CA.
  • Naumann RW; Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Wenham RM; Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL.
  • Rosengarten RD; Genialis Inc, Boston, MA.
  • Benjamin L; OncXerna Therapeutics Inc, Waltham, MA.
  • Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.
  • Moore KN; Tennessee Oncology, Nashville, TN.
J Clin Oncol ; 40(23): 2568-2577, 2022 08 10.
Article em En | MEDLINE | ID: mdl-35439029

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias das Tubas Uterinas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias das Tubas Uterinas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article